Study ID: ABS-COPD-30065

Study Title

Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Teva Identifier

ABS-COPD-30065

ClinicalTrials.gov Identifier

NCT03256695

Study Status

Completed

Trial Condition(s)

Chronic Obstructive Pulmonary Disease

Interventions

Drug: Albuterol sulfate (ABS)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

40 Years and older

Trial Duration

September 28, 2017 - April 17, 2018

Phase

Phase 3

Study Type

Interventional